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Abstract 
The Effect of Compliance Changes on Delivered Tidal Volumes and Amplitude in an 
Adult Patient Ventilated with High Frequency Oscillatory Ventilation: A Bench Model  
By 
John A. England 
 
Clinical concerns exist regarding the delivered tidal volume (Vt) during high-
frequency oscillatory ventilation (HFOV). HFOV is increasingly being used as a lung 
protective mode of ventilation for patients with Adult Respiratory Distress Syndrome 
(ARDS), but caution must be utilized.  The purpose of this study was to investigate the 
effect of airway compliance on Vt delivered by HFOV to the adult patient.  
Method: An in vitro model was used to simulate an adult passive patient with ARDS, 
using a high fidelity breathing simulator (ASL 5000, IngMar Medical). The simulation 
included independent lung ventilation with a fixed resistance and adjustable compliance 
for each lung. Compliances of 10, 15, 20 and 25 ml/cmH2O were used and resistance 
(Raw) was fixed at 15 cm H2O/L/s. The ventilator SensorMedics 3100B (Cardinal 
Health, Dublin, Ohio) was set to a fixed power setting of 6.0, insp-% of 33%, bias flow 
=30 L/min, and 50% oxygen and Hz of 5.0 (n=5) for each compliance setting.  Mean 
airway pressure (mPaw) and amplitude (AMP) varied as the compliance changes were 
made.  Approximately 250 breaths were recorded at each compliance setting and the data 
was collected via the host computer and transferred to a log to be analyzed by SPSS v. 
10.  
 Data Analysis: The data analysis was performed using SPSS v. 10 to determine 
the statistical significance of the delivered Vt with different compliances, different AMP 
and a fixed power setting. A probability of (p < 0.05) was accepted as statistically 
significant.  
Results: The average delivered Vt with each compliance was 124.181 mL (range 
of 116.4276 mL and 132.6637 mL) and average AMP of 84.85 cm/H2O (range 82.0 
cm/H2O and 88.0801 cm/H2O) n=5. There was an inverse relationship between Vt and 
AMP at a fixed power of 6.0.  As compliance improved Vt increased and there was a 
corresponding decrease in AMP.  The one-way ANOVA test showed that there were 
significant differences between the delivered tidal volume and AMP at a fixed power 
setting. When the post hoc Bonferroni test was used the data showed significant 
differences between AMP achieved with each compliance change and a fixed power of 
6.0. When the post hoc Bonferroni test was used the data showed significant differences 
between Vt delivered with each compliance change and a fixed power setting of 6.0.       
Conclusion: Vt is not constant during HFOV. Compliance is one determinant of 
Vt in adults with ARDS during HFOV.  AMP and Vt are inversely related during HFOV 
at a fixed power setting and improving compliance.
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Chapter I 
Introduction 
Historical Perspective 
 The field of respiratory care a relative new comer in the world of modern 
medicine.  In 1947 the predecessor of the present day American Association for 
Respiratory Care (AARC) was chartered in the State of Illinois and called Inhalation 
Therapy Association.    The role of the respiratory therapist has changed also from its 
modest beginnings of setting up simple oxygen (O2) devices and cylinders in 1947 to 
being recognized as healthcare professionals charged with the responsibility of 
maintaining the 26 week gestational age, 500 gram neonate to the adult patient in 
respiratory failure on conventional and non-conventional ventilation.  Present day 
therapists are considered experts in many areas but especially ventilator management.  
They are also becoming actively involved in relevant and timely research.   
High Frequency Oscillation Ventilation 
 One innovation in respiratory care is High Frequency Oscillatory Ventilation 
(HFOV).   HFOV is described as a ventilator that delivers a rate greater than 150 breaths 
a minute.  HFOV achieves gas transport with stroke volumes approximating anatomic 
dead space and HFOV can be viewed as a mixing device that rapidly blends high O2/low 
carbon dioxide (CO2) gas from the top of the endotracheal tube with gas in the alveoli.  
Net transport occurs along the partial pressure gradients for O2 and CO2, with CO2 
moving out of the lung along its partial gradient and O2 moving inward to the alveolar 
capillary interface.  These flow oscillations cause symmetric oscillations of 
intrapulmonary pressure around a mean distending airway pressure (Tobin, 2006). 
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 According to the manufacturer, oxygenation and ventilation are considered 
mutually exclusive.  Oxygenation is achieved by the mean airway pressure (mPaw) 
delivered by the oscillator or the FiO2.  Ventilation is primarily determined by the stroke 
volume of the device.  Stroke volume is determined by the Delta-P of the frequency.  
Figure 1 is a representation of the front panel of the 3100 B HFOV.  
 Mean                             Amplitude (Delta-P)       Power Knob              Flow         
 
   Percent Inspiratory Time Frequency (Hz) 
Figure 1. Front Panel of the Model 3100B HFOV.  Reprinted with permission by 
Cardinal Health Inc. 2009 
 HFOV produces a waveform similar to a sine wave.  The amplitude (AMP) of the 
wave is determined by the power setting of the vent.  The power setting also determines 
the forward and backward motion of the piston which helps determine tidal volume.  
Mean airway pressure is generated by a continuous flow of gas past a variable resistance 
mushroom valve located on the expiratory limb of the patient’s circuit (Pilbeam & Cairo, 
2006).      
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 A brief timeline of Premarket Approvals (PMA) is provided for FDA approval in 
the use of HFOV in the adult patient with Adult Respiratory Distress Syndrome (ARDS).   
 
 
Figure 2. Brief timeline of Premarket Approvals for HFOV  
 On March 29, 1991, a PMA was approved for the SensorMedic 3100 High 
Frequency Oscillatory Ventilator (Cardinal Health, Dublin, Ohio) for the treatment of 
neonates with respiratory failure and barotrauma.  On September 15, 1995, a PMA 
supplement was issued expanding the indications for use of the Model 3100A to include 
certain pediatric patients who were failing conventional ventilation.   On September 6, 
2001 the FDA approved a PMA for the use of the Model 3100B for the ventilatory 
support and treatment of selected patients 35 kilograms or greater in acute respiratory 
failure (Summary, p890057s, p7).  
 Figure 3 is an introduction to the major gas transport mechanisms under 
physiologic conditions during HFOV.  The major mechanisms of gas transport and 
exchange include:  Taylor Dispersion, gas on inspiration will travel down the center of 
the airway and expired gas will travel along the walls of the airway, Pendeluft movement 
of gas, because of the differences in compliance and resistance lung areas flow will go to 
the areas of the lunge with the greatest compliance and least resistance. There is also a 
component bulk movement of gas similar to conventional ventilation.  
  3100 Approval      3100A approval  3100B approval  
 
              3/29/1991           9/15/1995       9/6/2001 
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 The major gas-transport mechanisms that are operative under physiologic conditions in 
each region (convection, convection and diffusion, and diffusion alone) are shown in 
figure 3. There are seven potential mechanisms that can enhance gas transport during 
high-frequency ventilation: turbulence in the large airways, causing enhanced mixing; 
direct ventilation of close alveoli; turbulent flow with lateral convective mixing; 
pendelluft (asynchronous flow among alveoli due to asymmetries in airflow impedance); 
gas mixing due to velocity profiles that are axially asymmetric (leading to the streaming 
of "fresh" gas toward the alveoli along the inner wall of the airway and the streaming of 
"alveolar" gas away from the alveoli along the outer wall); laminar flow with lateral 
transport by diffusion (Taylor dispersion); and collateral ventilation through nonairway 
connections between neighboring alveoli (Slutsky & Drazen, 2002).  
 
Figure 3. Gas-Transport Mechanisms during High-Frequency Ventilation  Slutsky A and 
Drazen J. N Engl J Med 2002; 347:630-631 reprinted with permission by The New 
England Journal of Medicine 2009 
 Fan and Stewart’s (2000) article supported the use of lower tidal volumes to 
prevent lung injury and lower the incidence of mortality and reduce the number of 
conventional ventilatory days.   This technique has been used since 2001 for the 
treatment of ARDS in the adult ICU population.  The benefits of HFOV in the adult  
patient is supported by the ARDSNet protocol of using small tidal volumes to ventilate a 
patient with the clinical result of less barotrauma to the patient (Fan & Stewart, 2006). 
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Statement of problem 
 Clinical practitioners have consistently observed that over the first forty-eight to 
seventy-two hours of initiating the use of HFOV in the adult patient the mPaw and the 
AMP will spontaneously drop. This will happen without any intervention on the part of 
the clinicians taking care of the patient.  The power setting (driving the AMP) and the 
flow will remain as originally set.  Currently, the reason for this decrease in pressure is 
not known; therefore, the purpose of this bench study is to determine if improvement in 
the patient’s compliance results in a change in the volume delivered with each stroke of 
the piston.   
 This is important from a clinician’s perspective.  If you increase the driving 
pressure to its original setting and the tidal volume increases, then are you putting the 
patient at higher risk of developing barotrauma, lung damage including a pneumothorax 
because of the increased tidal volume?  From a retrospective chart review of the 
management of patients on HFOV at a local area hospital, it was learned that patients 
who had their AMP and mPaw returned to the original settings suffered a larger number 
of pneumothoraces than patients that were not returned to their original setting.  This led 
to the following research question: Is there a direct correlation with the AMP and Vt 
changing while on HFOV and the tidal volume delivered to the test lung? By knowing 
the answer to this question the therapist will be able to provide safer care to the patient.  
The realization that the patient’s lung compliance is changing for the better, the therapist 
will not return the ventilator to its original settings, thus preventing a possible 
pneumothorax by delivering a larger volume then needed.  This could lead to 
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transitioning back to conventional ventilation sooner and possibly a shorter ICU stay for 
the patient. This could possibly reduce the total cost of the patient’s hospital stay.  A 
shorter hospital stay reduces the patient’s risk of a nosocomial infection which is a 
complication of hospital care. 
This chapter describes the role of the respiratory therapist in one aspect of critical 
care: the management of HFOV and the importance of an astute respiratory therapist with 
the understanding of how HFOV is assumed to work and the relevance of the values 
reported on the oscillator.  The understanding of the relationship of Vt and lung 
compliance to the spontaneous drop in AMP will provide safer environment for the 
patient.  
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Chapter II 
Review of the Literature 
Introduction 
This literature review will cover the topics of HFOV as it relates to its uses and 
benefits to the adult patient.  Sources cited come from a variety of scholarly medical 
journals using CINAHL Plus with Full Text: Nursing and Allied Health (at 
EBSCOhost), MEDLINE with full text (at EBSCOhost) and PubMed databases.  The 
reviews were collected using the terms high frequency oscillatory ventilation and 
compliance changes using HFOV as it pertains to the adult patient.  Very few articles 
pertaining to HFOV and the adult patient were found.  This review is reflective of 
current ventilatory strategies utilizing HFOV.   
Indications for HFOV 
There are few articles that describe the indications for HFOV in the adult patient; 
five of these articles are summarized for this review. 
Cartotto et al. (2005) article “studied 25 burn patients with 24 of them meeting the 
criteria for ARDS”.  ARDS has an acute onset and occurs from a loss of surfactant due 
to the leakage of proteinaceous fluid into the pulmonary interstitium and alveoli causing 
a loss of surfactant reducing the compliance in the lungs. There is a heterogeneous 
appearance on a chest X-ray. Pulmonary artery pressure will usually be less than 18 
mmHg, if the patient does not have a pulmonary arterial catheter in place the patient will 
not be showing signs of left heart failure.  The patients in Cartotto’s study had a 
PaO2/FiO2 (PF) ratio of 98 ± 26.  A PF ratio of ≤ 300mmHg is by definition Acute Lung 
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Injury (ALI) and a PF ratio of ≤ 200 is considered ARDS.  Oxygen index (OI) (FiO2 X 
MAP X 100/PaO2) of 27 ± 10 just prior to initiating HFOV.   Six of the patients were 
receiving inhaled nitric oxide (iNO) at a level of 16 ± 6 ppm.  Within one hour there was 
a sustained increase in the P/F ratio and within 48 hours a continual decrease in the OI.  
All of the patients receiving iNO were weaned off within 24 hours of starting HFOV.  
HFOV was maintained for 6.1 ± 5.8 days (range of 2 hrs to 26 days).  Seven patients 
died, their underlying cause was sepsis with multiple organ failure.  The 18 survivors 
were converted back to controlled mandatory ventilation at a FiO2 of .40 ± 0.1 and a 
mPaw of 24.4 ± 4.0 cm H2O. 
 Chan et al. (2005) wrote a literature review from articles written between 1980 to 
2004 on HFOV.  Chan reviewed eight clinical trials of various methodological designs.  
All of these studies showed that HFOV lead to an improvement in oxygenation.  Chan 
also reported that refractory oxygenation can improve with the utilization of HFOV and 
iNO.  He concluded that HFOV can be a safe and effective mode of ventilation in the 
adult patient with ARDS.  Earlier intervention of HFOV is a recommendation of his 
literature review. 
 Imai et al.’s (2005) article reviewed several studies using small animal models 
and the effects of HFOV on lung damage.  The animals had lung damage induced by lung 
lavage to cause a low surfactant state.  It was concluded in this article that HFOV can 
reduce ventilator induced lung injury (VILI) compared with conventional ventilator 
strategies.  However, early neonatal studies did not support this conclusion (The HIFI 
study Group, 1989).  The use of lung recruitment measures in the neonate did show an 
overall improvement in gas exchange.  The author concluded that there is convincing
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animal data supporting the use of lung protective strategies such as HFOV in the adult patient.   
 Venegas et al. (1991) concluded that as tidal volume increases, gas transport changes 
from inefficient dispersion to more efficient bulk movement of gas, with regional tidal volume to 
dead space ratios.  These findings are consistent with other large animal studies.  This review 
showed that gas exchange mechanisms during HFOV are accomplished by laminar flow, 
turbulent dispersions, mixing due to asymmetrical velocity profiles, and pendelluft breathing.  
These results were accomplished by using large animal experimentation. 
 Bollen et al. (2005) compared the safety and efficacy of HFOV with conventional 
ventilation (CV) for early intervention of adult respiratory distress syndrome (ARDS).  A 
randomized trial in four intensive care units was conducted.  The patients were randomized to 
receive either conventional ventilation or HFOV.  The trial was stopped early because of a low 
inclusion rate (61 patients) and the completion of another trial comparing HFOV and 
conventional ventilation but did conclude that in patients with ARDS with higher baseline OI 
might benefit from HFOV. 
Mechanism of HFOV 
 The mechanism of how HFOV works is not fully understood.   The following articles will 
discuss some of the most current ideas. 
Pillow’s (2005) article collected data from studies indexed in PubMed illustrating key 
concepts relevant to pressure transmission in the adult lung using a published theoretical model.  
The article reviewed the mechanisms of gas exchange and transport during HFOV.  Gas 
transport during HFOV is accomplished through bulk movement of gas, diffusion, convection, 
pendelluft and cardiac mixing and the roles they play in gas exchange.  The article also 
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introduced the bifurcation phenomenon and how gas streams fresh gas towards the alveoli along 
the inner airways while “alveolar” gas is streamed away from the alveoli along the outer wall.  
 This phenomenon plays an important role in the longitudinal convective transport 
mechanism during HFOV.  The author concluded that the clinician needs to be aware that 
HFOV adds a complexity that conventional ventilation lacks.  The changes in compliance and 
resistance of the patient and how these will influence clinical decisions at different frequencies, 
flow and pressure transmitted to the lung must be understood.  Clinicians must understand how 
drops in mean airway pressure across the endotracheal tube could be altered by changing the 
frequency, internal diameter of the endotracheal tube, and ventilator amplitude. 
Carney et al.  (2005) reviewed original published articles and review papers dealing with 
the mechanism of lung volume changes at the alveolar level.  The authors explain that it has 
been suggested that the lung volumes change by alveolar recruitment and derecruitment.  This 
postulate suggests that the alveolus do not change size during ventilation.  Smaldone et al. 
(1983) demonstrated in their in vivo studies that the normal lung changes volume by alveolar 
recruitment and derecruitment.  The author also stated that data from their own laboratory 
suggests that normal alveoli do not change size during ventilation.  Also, they found that large 
changes in alveolar size and widespread alveolar recruitment and derecruitment appear 
dominant in acute lung injury.  Tremblay et al. (1997) demonstrated that ventilating normal 
excised lungs with very high inspiratory pressure and low positive end expiratory pressure 
(PEEP) caused injury demonstrated by the release of inflammatory cytokines.  Carney et al. 
(2005) also states that unstable alveoli that open and close with each breath can cause a 
significant shear stress lung injury.  This study concluded that ventilator maneuvers that 
stabilize the alveolus such as PEEP and HFOV may help to reduce the incidence of VILI.   
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Other Uses of HFOV 
Cartotto et al.’s (2005) article suggests a way that his team transported burn 
patients to the operating room (OR).  It consisted of clamping the patient’s ET tube to 
maintain FRC and switching to a manual resuscitator with 20 cm H2O PEEP.  During the 
transport the patient would then be given quick small breaths with a resuscitation bag.  
Prior to reinitiating HFOV in the OR, a recruitment maneuver would be performed and 
oscillation then would be started.  Cartotto’s team has transported 18 patients requiring 
surgery to the OR. His conclusion is that HFOV was useful in the transporting of burn 
patients with ARDS.  The author suggests that further randomized clinical trials are 
needed to assess the usefulness of HFOV. 
 This review of the preceding three categories: indications for HFOV, mechanism 
of HFOV and other uses demonstrates the general lack of published clinical guidance for 
the bedside clinician as it pertains to HFOV.  More research is needed to fully understand 
HFOV, and to give guidance to the bedside clinician.  The purpose of my study was to 
help the clinician to better understand the relationship between changing lung compliance 
and delivered tidal volumes in the use of HFOV.
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Chapter III 
RESEARCH METHODS 
Lung Model 
An in vitro model was used to simulate the adult patient with ARDS using a high 
fidelity breathing simulator (Active Servo Lung (ASL) 5000, Ingmar Medical, Pittsburgh, 
PA, USA) to answer the following question: does changing lung compliance change the 
volume delivered to a patient on HFOV.  The ASL 5000 is digitally controlled, and is 
piston-driven simulating real time breathing.  
Ventilator Settings 
The SensorMedics 3100B ventilator was used with a standard HFOV adult circuit 
and a cuffed endotracheal tube size 8.0 mm internal diameter (I.D.) (Portex). The 3100B 
HFOV parameters were set for an adult patient with ARDS according to Fessler et al., 
(2007) guidelines.  Fessler et al., (2007) recommended the guidelines to optimize the lung 
protective characteristics of HFOV.   The 3100B ventilator was set at a power of 6, 33% 
inspiratory time (Ti), frequency (f) of 5 Hz, mPaw varied to reflect the compliance that 
was set on the ASL 5000, bias flow (BF) of 30 L/min and 50% oxygen. 
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Protocol 
To simulate an adult patient with severe ARDS on HFOV the ASL 5000 scenario of 
an adult passive patient with changeable compliance and fixed resistance (Raw) for each 
lung was varied at the following settings; the resistance was set during the experiment at 
15cm H2O/L/s and the compliance was 10, 15, 20 and 25 mL/cm H2O (Protocol is 
included in Appendix A). 
The 3100B ventilator circuit was calibrated then set to the previous mentioned 
settings.  The ASL 5000 was connected to the ventilator (Figure 4) with a standard high-
frequency breathing circuit and size 8.0 mm I.D. cuffed ETT. The ASL 5000 was 
connected to the software host computer via Ethernet cable. Vt and total delivered 
number of breaths were measured inside the test lung and recorded by the software host 
computer.  
 
 
 
 
 
 
 
 
Figure 4. Schematic drawing of the experiment set-up 
 
Test Lung                 ET Tube 
 
 
HFOV Piston 
Computer 
Cable 
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Data Collection 
Vt was measured and recorded five times (n = 5) for each level of compliance. 
The measuring was done by ASL 5000 software at the same ventilator settings. 
Approximately 250 breaths of data for each level of compliance was captured via the 
ASL software and the volume of the 250th breath was recorded to be used in the analysis.  
The number of breaths (250) was determined graphically; this is where the volume 
delivered to the lung to plateau.  This value is felt to be more reflective of what happens 
physiologically in the lung then taking an average of the 250 breaths, because the drop in 
AMP happens once a steady state is reached in the lung.   By reviewing the captured data 
Vt and amplitude was recorded and analyzed.  
 Data Analysis: The data analysis was performed using SPSS v. 16 one way 
ANOVA, post hoc Bonferroni, descriptive statistics, Post hoc comparison and Pearson 
correlation test to determine the statistical significance of the delivered Vt and AMP 
measurements with different compliance settings. A probability of (p < 0.05) was 
accepted as statistically significant. 
 In summary, this chapter described the methods used to investigate the 
relationship between changing lung compliance and delivered tidal volumes in the use of 
HFOV.  Data was collected using the 3100B connected to a simulator and analyzed using 
SPSS v.16. 
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Chapter IV 
Results  
 The data outlined in this chapter are provided to assist in answering the following 
question: is there an effect on volumes delivered in an adult patient ventilated with 
HFOV as lung compliance change. For each trial an average of 250 breaths were 
delivered by the 3100 B ventilator, the power was fixed at 6.0, the flow was set at 30 lpm 
and the Hz was set at 5.0. The following tables reflect the statistical analysis for the 
change in volume as the compliance is varied:   
Tidal Volume as it Relates to Compliance 
 Table 2 reflects the descriptive statistical analysis of the four compliance settings 
as compared to the volume delivered.  The mean volumes increase as the compliance 
improves and the power driving the piston remains constant.  
Table 1. Descriptive Statistics volume compared to compliance change  
 Compliance        n     Mean Std. Deviation   Minimum   Maximum 
                           
10 mL/cmH2O      5 117.6380        0.97482    116.36    118.87 
 15 mL/cmH20      5 121.7260        1.46290    119.64    123.42 
 20 mL/cmH2O     5 125.2420        1.49224    123.58    126.99 
 25 mL/cmH2O     5 132.1180        0.43951    131.68    132.85 
   Total                  20 124.1810        5.55754    116.36        132.85 
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          The one way ANOVA (Table 3) test showed that there was a significant 
difference between delivered tidal volumes and improving compliance at a fixed power 
setting.   
Table 2. Anova table comparing volumes between groups 
  
 
 
 
   
 Mean Square    F  Sig. 
Between Groups 188.266 136.665 0.000 
Within Groups 1.378 
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 When the post hoc Bonferroni test (Table 4) was run, it showed specifically that 
as each level of compliance was manipulated the tidal volume was directly related to it.  
These measurements were performed at a power setting of 6.0.   
Table 3. Multiple Comparisons Dependent Variable: Volume Bonferroni Analysis 
    
  Mean Difference (I-J)         Std. Error        Sig.   95% Confidence 
Interval 
 (I)  Compliance  (J)  Compliance    ___________ 
10                      15      -4.08800  0.74231   0.00*  
 20      -7.60400  0.74231   0.00*  
 25     -14.48000  0.74231   0.00*    
15 10       4.08800  0.74231   0.00*       
 20      -3.51600  0.74231   0.00*      
 25    -10.39200  0.74231   0.00*    
20 10       7.60400  0.74231   0.00*       
 15       3.51600  0.74231   0.00*       
 20      -6.87600  0.74231   0.00*      
25 10      14.48000  0.74231   0.00*     
 15      10.39200  0.74231   0.00*  
 20       6.87600  0.74231   0.00*  
Compliance = mL/cmH2O  
* The mean difference is significant at the 0.05 level. 
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Amplitude as it Relates to Compliance 
 
   
 For each trial an average of 250 breaths was delivered by the 3100 B ventilator, 
the power was fixed at 6.0, the flow was set at 30 lpm and the Hz was set at 5.0. The 
following table reflects the descriptive statistics for the change in amplitude as the 
compliance is varied.  An average of 250 breaths was used as the target number of 
breaths, because this was reflective of a steady state tidal volume delivered by the 
ventilator, as reflected by the reading on the simulator.  
 Table 5 reflects the descriptive statistical analysis of the four compliance settings 
as compared to the measured amplitude.  The mean amplitude decreases as the 
compliance improves and the power driving the piston remains constant.  
 Table 4. Descriptive Statistics amplitude to compliance change  
  
 
  
 
  
 
 
 
 
 
 
        n     Mean Std. Deviation   Minimum   Maximum 
10 mL/cmH2O     5    87.4000         0.54772  87.00      88.00   
15 mL/cmH20      5   86.0000        0.00000 86.00      86.00 
20 mL/cmH2O     5    84.0000        0.00000 84.00      84.00 
25 mL/cmH2O     5   82.0000        0.00000 82.00      82.00 
        Total      20 84.8500        2.10950 82.00      88.00 
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 The one way ANOVA test (Table 6) showed that there was a significant 
difference between measured amplitude and improving compliance at a fixed power 
setting.   
Table 5. Anova table comparing amplitude between groups 
 
 
 
 
 
 
 Mean Square     F Sig. 
Between Groups 27.783 370.444 0.00 
Within Groups 0.075 
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 When the post hoc Bonferroni test (Table 7) was performed, it showed 
specifically as each level of compliance was manipulated the amplitude was directly 
related to it.  These measurements were all conducted at a power setting of 6.0.   
Table 6. Multiple Comparisons Dependent Variable: Amplitude Bonferroni Analysis 
 
 
   
  
  
               Mean Difference (I-J)        Std. Error          Sig.   95% Confidence Interval 
(I)  Compliance (J) Compliance                         
 10 15              1.40000 0.17321 0.000*  
 20   3.40000 0.17321 0.000*  
 25   5.40000 0.17321 0.000*  
 15 10  -1.40000 0.17321 0.000*  
 20   2.00000 0.17321 0.000*  
 25   4.00000 0.17321 0.000*  
  20 10 -3.40000 0.17321 0.000*  
15             -2.00000 0.17321 0.000*  
25              2.00000 0.17321 0.000*  
25                      10 -5.40000 0.17321 0.000*  
15    -4.00000 0.17321 0.000*  
20            - 2.00000 0.17321 0.000*  
Compliance = mL/cmH2O  
*The mean difference is significant at the 0.05 level. 
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 When Pearson correlation was performed, it showed a significant inverse 
correlation between amplitude and tidal volume.  These measurements were all 
conducted at a power setting of 6.0.  
 
Table 7: Pearson Correlation between Amplitude and Tidal Volume  
 
 
  
 
 
 
 
 
 In summary the research question was answered; the spontaneous reduction of 
amplitude is indicative of improving compliance.  As also shown by this study it is an 
inverse relationship. As amplitude decreased, tidal volume increased. Therefore, 
clinicians caring for the patient should be aware of possible physiologic changes to the 
patient. 
 
 
Correlations 
AMPS VOL
VOL Pearson
Correlation
-.969 1
Sig. .000 .
N 20 20
**  Correlation is significant at the 0.01  
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Chapter V 
Discussion 
 This chapter is a discussion of how lung compliance changes effect delivered tidal 
volume during HFOV.  According to this study during HFOV as lung compliance 
improves, AMP will drop and Vt will increase. With this knowledge clinicians can treat 
their patients safer by decreasing length of stay on a ventilator.  
 In clinical practice it has been observed that the amplitude and mean airway 
pressure will decrease, as measured by the ventilator, usually within the first 48 to 72 
hours. This happens with no change to the power setting driving the piston.  As 
demonstrated by this study; as lung compliance improves, tidal volume will increase and 
amplitude will decrease with no change in the power setting.   Extrapolating upon this 
data, if the clinician were to increase the power to the piston to achieve the original 
amplitude the tidal volume delivered from the ventilator will increase.  This will be 
detrimental to the patient for two clinical reasons.  First, the current treatment of ARDS is 
low tidal volume, high PEEP and lower alveolar pressures.  If adequate volume can be 
maintained at lower ventilating pressures; there is no reason for a clinician to potentially 
cause further pulmonary barotrauma by increasing the volume delivered by increasing the 
power setting to achieve the original amplitude.  Secondly, because the patient’s lung is 
non-compliant, increasing the power (amplitude) and correspondingly the tidal volume, 
the clinician puts the patient at risk for developing a pneumothorax.  Even though it 
appears to be an insignificant increase in Vt 14 mL from the least compliant to the most 
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compliant this number is equivalent to a minute volume of 5.2 L which is a significant 
increase and could potentially be detrimental to the patient. 
 There are limitations to the generalizations of this study. It was a bench study and 
this may not be what happens physiologically to the patient but the results are believed to 
be reflective of what happens in clinical practice.  The gas delivered to the ASL 5000 was 
not heated or humidified, as recommended by the manufacturer to prevent damage to the 
ASL 5000.  This is not reflective of what happens in clinical practice.  In clinical 
practice, any time a patient is placed on HFOV the gas being delivered to the patient will 
be heated and humidified.  The number of trials was small in number but sufficient to 
support what happens in clinical practice. In clinical practice, amplitude will decrease as 
lung compliance improves and as reflected by this bench study, amplitude did decrease 
spontaneously with improving compliance. This resulted in an increase in delivered tidal 
volume. The fact that this bench study does not necessarily reflects what happens to a 
patient on HFOV makes this a shortcoming.  
 A question that has also frustrated clinicians is: Many patients who are placed on 
HFOV are refractory to oxygenation and in attempt to reverse this condition iNO is 
initiated shortly after HFOV with little or no success.  But if iNO were to be reinstated 24 
to 48 hours later will there be an improvement in oxygenation?  For iNO to be effective it 
must travel through the alveolus into the vasculature causing smooth muscle relaxation 
and arteriolar dilation (INOmax). As demonstrated by this study, as compliance of the 
lung improves, as seen by a decrease in amplitude and an increase in tidal volume, does 
this then reflect an increase in the functional residual capacity of the patient allowing 
more alveolar surface area for iNO to travel into the vasculature?  In clinical practice iNO 
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is used in the premature infant for refractory hypoxemia. Institutions that use iNO in their 
NICUs also use iNO with their adult patients and found an increase in the reversal of 
hypoxemia and pulmonary hypertension.  Building upon these clinical observations, iNO 
has made its way into the adult ICU even though it is considered off label in many 
instances. To build upon this study a follow up survey of users of HFOV and their 
success in reversing refractory hypoxemia using iNO and HFOV versus conventional 
ventilation should be investigated. 
 The use of HFOV in the treatment of ARDS is still considered by many to be a 
rescue modality.  It is incumbent upon us as respiratory therapists to inform the medical 
community that the early use of HFOV may be helpful to the patient.  The use of HFOV 
allows the respiratory therapist to deliver smaller tidal volumes at lower pressure and still 
maintain adequate alveolar ventilation.  HFOV is not a modality stressed in the medical 
or clinical education of current critical care physicians.  With proper training of  critical 
care respiratory therapists and nurses it can become another adjunct in the treatment of 
this disease. Early intervention with HFOV has been shown to help in the treatment of 
ARDS but until the medical community is comfortable with this modality it will remain 
as a rescue device only.    
 To conclude, this study showed; there is an indirect correlation with AMP and Vt. 
As compliance improves the tidal volume, delivered to a patient on HFOV will increase 
and the AMP will decrease. 
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Definitions 
Premarket Approval (PMA) - any premarket approval application for a class III medical 
device, including all information submitted with or incorporated by reference. "PMA" 
includes a new drug application for a device under section 520(l) of the FD&C Act. 
Functional Residual Capacity (FRC) - this is the lung volume at the end of a normal 
expiration, when the muscles of respiration are completely relaxed 
Lung compliance - the ease in which a structure distends. Mathematically lung 
compliance is volume change divided by pressure change.  Normal lung compliance of 
the lung is 0.1 L/cmH2O. 
Tidal Volume – the amount of air inspired and expired during one normal breath. 
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APPENDIX 
Appendix A 
Protocol 
High-Frequency & Tidal Volume 
Goals: 
• To determine the delivered Vt at a predetermined lung compliance 
• To examine the influence of lung compliance on the delivered Vt (n=5 for 
 each compliance) 
Methods: 
• For lung compliance 10 mL/cm H2O do five trials as follow; 
 A) Test lung 
  1. Use ASL 5000 breathing simulator. 
  2. Connect the simulator ASL 5000 to line power then switch it on. 
   i. The Motor red light is enabled. 
   ii. Wait for the Motor red light to turn off. 
   iii. ASL 5000 is calibrated and ready to be connected to the  
    ventilator and computer. 
  3. Connect the ASL 5000 to the host PC via Ethernet networking cable. 
  4. Connect the ASL 5000 with HFOV through standard high-frequency 
  breathing circuit and size 8.0 mm I.D. cuffed ETT. 
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 B) Ventilator 
  1. Use SensorMedics 3100B   
  2. Calibrate the 3100B ventilator with capped standard high-frequency  
   breathing circuit; 
    i. Set bias flow at 30 L/min. 
    ii. Mean Airway Pressure (mPaw) to maximum. 
    iii. Pressure amplitude (delta-P) of 60 cm H2O. 
    iv. Set inspiratory time (I-time) to 33%. 
    v. Start the 3100B ventilator wait for the mPaw reading to  
    reach between 40 & 45 cm H2O.   
  3. Set the 3100B ventilator to the following; 
   i. Set power to 6.0; pressure amplitude reading will be variable. 
   ii. Frequency (f) of 5 Hz. 
   iii. Mean Airway Pressure will be variable. 
   iv. Set bias flow at 30 L/min. 
   v. I-time to 33%. 
   vi. Oxygen to 50%. 
  4. Connect the standard high-frequency breathing circuit and size 8.0 mm 
  I.D. cuffed ETT (Portex, Hythe Kent, England) to the ASL 5000. 
  5. Go to step (c – 9 – i). 
 C) Computer 
  1. After all necessary cable connections have been completed (step a – 3); 
  launch the LabView software on the host PC. 
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  2. Working page (welcome window) is presented; 
   i. From welcome window choose run the software with Ethernet  
    mode. 
   ii. Welcome window will disappear and several windows will be  
    stacking up on computer screen. 
   iii. Host computer will attempt to synchronize with the ASL 5000. 
   iv. Wait for ASL 5000 response (simulator piston will move). 
 3. From the Script Editor window chose (Adult_apnea.sct) file to   
  edit its  model  parameter files. 
  4. From the Script File‖ box click two times on the file name   
   (Adult_apnea.sct). 
  5. A window titled "Step 1: Select Simulation Parameter Set" will open. 
   i. Click edit to proceed to the next step. 
  6. A window titled step 2: choose a lung model‖ will open. 
   i. Chose the two compartment lung model. 
   ii. Set resistance (Raw1) to 15 cm H2O/L/sec. 
   iii. Set resistance (Raw2) to 15 cm H2O/L/sec. 
   iv. Set compliance (CL1) to10 mL/cm H2O. 
   v. Set compliance (CL2) to 10 mL/cm H2O. 
   vi. Click next. 
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  7. A window titled Step 3: Chest Wall Model‖ will open. 
   i. From chest wall model pop-up menu chose passive model. 
   ii. Set the passive cycle to 12 breathes per minute. 
   iii. Click next. 
  8. A window titled step 4: save simulation parameter set will open. 
   i. Click save, to save the new variables in the file. 
 
  9. From the Central Runtime Window while the ventilator is running and  
   connected to the ASL 5000 
   i. Start the simulation by moving the "slide switch from the off to  
   the on position. 
   ii. From file window chose a name for the data file path to store the 
   data. 
   iii. Click OK. 
  10. Go to Breath Detection / Real-Time Analysis window. 
   i. Check the save data to high resolution file checkbox. 
   ii. Wait for the data of 250 breaths to be collected. 
  11. Turn off the simulation by moving the "slide switch from the on to 
   the off position. 
 D) Data Collection 
  1. Launch the Lab VIEW software on the host computer. 
  2. Go to post-run window. 
   i. Choose the file to be displayed click it two times.
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   ii. Open multiple parameter trend from the green box under the 
   display data list. 
  3. Check the Vt waveform to establish the steady state. 
   i. The Vt increases gradually to build up the volume in the test  
   lung 
   ii. The steady state is when there is no more increase in the Vt  
   delivered   
  4. Review the volume waveform  
  5. Record the tidal volume and use it in data analysis. 
• For the compliance of 15, 20,and 25 mL/cm H2O do five trials as follow: 
1. Repeat steps 9 and 10  
2. Record data as explained in letter D 
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Appendix B: Raw data from trials: 
 
Comp 
ml/cmH2O  AMP  Vt  
Comp 
ml/cmH2O  
AMP  Vt  
Comp 
ml/cmH2O 
AMP  
Vt  
Comp 
ml/cmH2O 
AMP  Vt  
10  88  118.31  15  86  121.93  20  84  123.58  25  82  131.93  
 10  88  116.36  15 86  123.42  20  84  123.79  25 82  132.02  
10  87  118.87  15  86  121.02  20  84  126.99  25 82  132.85  
10  87  117.36  15 86  119.64  20  84  125.77  25 82  131.68  
10  87  117.29  15  86  122.62  20  84  126.08  25 82  132.11  
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